Biotech Values

[DewDiligence]

COV opens R&D facility in Shanghai:

http://www.financialpost.com/markets/news/Covidien+Opens+Million+Facility+China/7029326/story.html

Covidien, a leading global provider of healthcare products, today announced the official opening of its China Technology Center (CTC) Research and Development (R&D) facility in Shanghai. The CTC has two core focus areas:

• Design of Tailored Products: identify and develop products that are customized to meet the needs of China and other Emerging Markets.

• Discovery of Breakthrough Platforms in medical technology –utilize the unique skillsets and expertise of employees in Asia to create and develop new medical device technologies.

…The CTC complements Covidien’s other operations in China, which include 10 commercial offices, a manufacturing center and training facilities for healthcare professionals.